ScientiËc Program - WOC2012
ScientiËc Program - WOC2012
ScientiËc Program - WOC2012
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
CO-GLA-SU 301<br />
Sun 19 Feb<br />
End-stage Glaucoma: Challenges of<br />
Clinical Assessment, Surgical Versus<br />
Medical Treatment, and Visual Prognosis<br />
Presenters: Tarek Eid, Ahmad Mustafa, Gehad El-Nahry,<br />
Moustafa Yaqup<br />
Objectives: The course aims to instruct attendees about how to<br />
deal with a patient with end-stage glaucoma in terms of clinical<br />
assessment of diagnostic and progression parameters and<br />
various modalities of treatment of such patient and the impact<br />
of treatment and disease progression on visual prognosis.<br />
Summary of Content: The course will discuss an important<br />
topic that carries a major challenge in many regions of the world<br />
where a plenty of patients are seen for the first time with a<br />
severe form of glaucoma (end-stage). What are the criteria of<br />
defining advanced to end-stage glaucoma, what further<br />
investigations should be performed for these patients,<br />
evaluation of progression rates and continued visual loss.<br />
Evaluation and visibility of medical treatment with its recent<br />
advances will be addressed and adherence to treatment plan<br />
and follow-up schedule. Surgical treatment of these patients will<br />
be discussed in details with various techniques to achieve a very<br />
low target pressure, surgical hazards, wipe out phenomenon,<br />
and long-term glaucoma stability versus continued progression<br />
and visual loss in this highly advanced disease.<br />
Target Audience: General Ophthalmologists and Glaucoma<br />
Specialists<br />
Educational Level: Intermediate and Advanced<br />
IS-GLA-SU 302<br />
Sun 19 Feb<br />
10:30 - 12:00 Capital Suite 15<br />
13:30 - 15:00 Hall 7 - Tokyo Hall<br />
Cataract Surgery in Glaucoma:<br />
Adapting the Solutions to the Patients<br />
Organized by the European Glaucoma Society<br />
Chairpersons: Remo Susanna Jr, Carlo Traverso<br />
Moderators: Thierry Zeyen, Fotis Topouzis<br />
Panelists: Karim Tomey, Moustafa Yaqub, Anton Hommer,<br />
Fotis Topouzis, Remo Susanna Jr, Carlo Traverso, Thierry Zeyen<br />
13:30 Combined Surgery vs. Sequential Surgery<br />
13:40 Cataract Surgery After Filtration Surgery<br />
13:50 Filtration Surgery After Cataract Surgery<br />
14:00 Combined Surgery: Which Glaucoma Procedure for<br />
Which Patient<br />
14:10 Exfoliation: Is Earlier Cataract Surgery a Better Option<br />
14:20 Angle Closure and Lens Surgery<br />
14:30 Phacoemulsification after Acute Angle Closure Attack<br />
14:40 Cataract Surgery in POAG: Precautions<br />
IS-GLA-SU 303<br />
Sun 19 Feb<br />
New Therapeutic Approaches in<br />
Glaucoma<br />
Chairpersons: Paul Kaufman, Shibal Bhartiya, Neeru Gupta<br />
13:30 Mitochondrial Medicine, Marcelo Olarte<br />
13:40 Treating the Central Nervous System, Neeru Gupta<br />
13:50 Targeting the Lymphatics in Glaucoma, Yeni Yucel<br />
14:00 Nanomedicine for the Delivery and the Stabilization of<br />
Therapeutics to the Eye and Central Nervous System,<br />
Rutledge Ellis-Behnke<br />
14:10 Regeneration of the Visual System in Glaucoma,<br />
Keith Martin<br />
14:20 Rho-Kinase Inhibitors and Other Treatments in the<br />
Glaucoma Pipeline, Paul Kaufman<br />
14:30 Panel Discussion<br />
IS-COR-SU 304<br />
Sun 19 Feb<br />
Ptyergium<br />
13:30 - 15:00 Hall 1<br />
Chairpersons: Jose Gomes, Juan Murube, Claus Cursiefen<br />
13:30 Update: Pathogenesis of Pterygium: Lessons from<br />
Genome-wide Expression Analysis, Roger Beuerman<br />
13:40 Update: Modern Concepts of Pterygium Surgery,<br />
Juan Murube<br />
13:50 Limbal Stem Cell Deficiency in Pterygium: Current<br />
Treatment Concepts, Jose Gomes<br />
14:00 Special Considerations on Pterygium Surgery in<br />
Countries with High UV-exposure, Minas Coroneo<br />
14:10 Higher Order Aberrations and Corneal Scarring after<br />
Pterygium Removal: What to Do, Pedram Hamrah<br />
14:20 Update: Adjuvant Antiinflammatory and Antiangiogenic<br />
Therapy Against Recurrent Pterygium, Claus Cursiefen<br />
14:30 Panel Discussion<br />
14:45 Q&A Session<br />
IS-RET-SU 305<br />
Sun 19 Feb<br />
13:30 - 15:00 Hall 11<br />
13:30 - 15:00 Hall 2<br />
Cutting Edge for Treatment of Retinal<br />
Diseases<br />
Organized by Deutsche Ophthalmologische Gesellschaft (DOG)<br />
Chairpersons: Anselm Kampik, Karl-Ulrich Bartz-Schmidt,<br />
Antonia Joussen<br />
13:30 What is the Role of Laser Treatment in Retinal Vascular<br />
Diseases in the Era of Anti-VEGF-Therapy, Matus Rehak<br />
13:40 Are Steroids a Better or Additional Option to Treat Retinal<br />
Vascular Diseases, Antonia Joussen<br />
13:50 Artificial Vision-The Subretinal Approach, Karl-Ulrich<br />
Bartz-Schmidt<br />
14:00 Is Pharmacologic Vitreolysis an Option to Treat<br />
Vitreoretinal Diseases, Anselm Kampik<br />
14:10 Gen-therapeutic Approaches to Retinal Diseases,<br />
Knut Stieger<br />
14:20 How Small Should Instruments Go for Vitrectomy,<br />
Siegfried Priglinger<br />
14:30 Retinal Imaging-High Resolution and Wide Angle<br />
OCT-technology, Aljoscha Neubauer<br />
14:40 Discussion<br />
Sunday, 19 February 2012<br />
89<br />
Hall 11
Change language